Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential

Di-phenyl-di-(2,4-difluobenzohydroxamato)tin(IV)(DPDFT), a new metal-based arylhydroxamate antitumor complex, showed high in vivo and in vitro antitumor activity with relative low toxicity, but no data was reported regarding its pharmacokinetics and dependent toxicity. In this paper, a rapid, sensit...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunlan Li, Zhuyan Gao, Pu Guo, Qingshan Li
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Bioinorganic Chemistry and Applications
Online Access:http://dx.doi.org/10.1155/2012/210682
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546127433433088
author Yunlan Li
Zhuyan Gao
Pu Guo
Qingshan Li
author_facet Yunlan Li
Zhuyan Gao
Pu Guo
Qingshan Li
author_sort Yunlan Li
collection DOAJ
description Di-phenyl-di-(2,4-difluobenzohydroxamato)tin(IV)(DPDFT), a new metal-based arylhydroxamate antitumor complex, showed high in vivo and in vitro antitumor activity with relative low toxicity, but no data was reported regarding its pharmacokinetics and dependent toxicity. In this paper, a rapid, sensitive, and reproducible HPLC method in vivo using Diamonsil ODS column with a mixture of methanol and phosphoric acid in water (30 : 70, V/V, pH 3.0) as mobile phase was developed and validated for the determination of DPDFT. The plasma was deproteinized with methanol that contained acetanilide as the internal standard (I.S.). The photodiode array detector was set at a wavelength of 228 nm at room temperature and a linear curve over the concentration range 0.1~25 μg·mL-1 (r = 0.9993) was obtained. The method was used to determine the concentration-time profiles for DPDFT in the plasma after single intravenous administration with doses of 5, 10, 15 mg·kg-1 to rats. The pharmacokinetics parameter calculations and modeling were carried out using the 3p97 software. The results showed that the concentration-time curves of DPDFT in rat plasma could be fitted to two-compartment model.
format Article
id doaj-art-49ff964c14d94171adb994c7b04feb69
institution Kabale University
issn 1565-3633
1687-479X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Bioinorganic Chemistry and Applications
spelling doaj-art-49ff964c14d94171adb994c7b04feb692025-02-03T07:23:50ZengWileyBioinorganic Chemistry and Applications1565-36331687-479X2012-01-01201210.1155/2012/210682210682Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor PotentialYunlan Li0Zhuyan Gao1Pu Guo2Qingshan Li3School of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaSchool of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaSchool of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaSchool of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaDi-phenyl-di-(2,4-difluobenzohydroxamato)tin(IV)(DPDFT), a new metal-based arylhydroxamate antitumor complex, showed high in vivo and in vitro antitumor activity with relative low toxicity, but no data was reported regarding its pharmacokinetics and dependent toxicity. In this paper, a rapid, sensitive, and reproducible HPLC method in vivo using Diamonsil ODS column with a mixture of methanol and phosphoric acid in water (30 : 70, V/V, pH 3.0) as mobile phase was developed and validated for the determination of DPDFT. The plasma was deproteinized with methanol that contained acetanilide as the internal standard (I.S.). The photodiode array detector was set at a wavelength of 228 nm at room temperature and a linear curve over the concentration range 0.1~25 μg·mL-1 (r = 0.9993) was obtained. The method was used to determine the concentration-time profiles for DPDFT in the plasma after single intravenous administration with doses of 5, 10, 15 mg·kg-1 to rats. The pharmacokinetics parameter calculations and modeling were carried out using the 3p97 software. The results showed that the concentration-time curves of DPDFT in rat plasma could be fitted to two-compartment model.http://dx.doi.org/10.1155/2012/210682
spellingShingle Yunlan Li
Zhuyan Gao
Pu Guo
Qingshan Li
Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
Bioinorganic Chemistry and Applications
title Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
title_full Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
title_fullStr Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
title_full_unstemmed Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
title_short Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
title_sort pharmacokinetic study of di phenyl di 2 4 difluobenzohydroxamato tin iv novel metal based complex with promising antitumor potential
url http://dx.doi.org/10.1155/2012/210682
work_keys_str_mv AT yunlanli pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential
AT zhuyangao pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential
AT puguo pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential
AT qingshanli pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential